Background: In Nigeria Pentavalent vaccine had replaced Diphtheria-Pertussis- Tetanus [DPT] vaccine in the prevention of pertussis since 2012. Aims and Objectives: The aim of this study was to compare the anti-pertussis immunoglobin G (IgG) response of children who received DPT with those who received the pentavalent vaccine. Subjects and Methods: This study was carried out in Akpabuyo LGA of Cross River State from April to June 2016. It was a cross-sectional survey of anti-pertussis IgG levels in children aged 6 months to 5 years who received DPT and those who received pentavalent vaccine. IgG antibody levels were determined using enzyme-linked immunosorbent assay. The protective level was set at >11 DU according to manufacturer’s cut off point. Results: Seventy eight out of 230 children [33.9%] who had received DPT had protective levels of anti-pertussis IgG compared to 74 out of 192 children [38.5%] who had received pentavalent vaccine. The difference was not statistically significant [p = 0.61]. The median IgG antibody level in those who received DPT was 8.0 DU (interquartile range (IQR) 4.0 - 13.0) compared with 9.0 DU (IQR) 4.0 - 15.0 in those who received pentavalent vaccine [p = 0.18]. No single factor investigated predicted the development of protective levels of antibody in the multivariate analysis. Conclusion/Recommendation: There was no difference in the antipertussis antibody response between DPT and pentavalent vaccines recipients. Further study is needed to elucidate factors that could be responsible for low anti-pertussis antibody response in this population.
References
[1]
Tindade, E. and Skowronski, D. (2005) Epidemiology of Pertussis. Pediatric Infectious Disease Journal, 24, 810-818. https://doi.org/10.1097/01.inf.0000160708.43944.99
Edward, K. and Freeman, D.M. (2006) Adolescent and Adult Pertussis: Disease Burden and Prevention. Current Opinion Pediatrics, 18, 77-80.
[4]
Banberger, E.S. and Srugo, I. (2008) What Is New in Pertussis. European Journal of Pediatrics, 167, 133-139. https://doi.org/10.1007/s00431-007-0548-2
[5]
Matoo, S. and Cherry, J.D. (2005) Molecular Pathogenesis, Epidemiology and Clinical Manifestations of Respiratory Infection Due to Bodertella pertussis and Other Bordetella Species. Clinical Microbiology Reviews, 18, 26-82. https://doi.org/10.1128/CMR.18.2.326-382.2005
[6]
Abdukarim, A.A., Ibrahim, R.M., Fawi, A.O., Adebayo, A.O. and Johnson, A.W. (2011) Vaccines and Immunization: The Past, Present and Future in Nigeria. Nigerian Journal of Paediatrics, 38, 186-194. https://doi.org/10.4314/njp.v38i4.72382
Alexandre, P., Aparcida, S., Pietro, P., Celio, L.S., Guternberg, R., Ivo, L. and Osvalda, A. (2010) Antibody Response from Whole-Cell Pertussis Vaccine Immunized Brazillian Children against Different Strains of Bordetella pertussis. American Journal of Tropical Medicine and Hygiene, 4, 678-682. https://doi.org/10.4269/ajtmh.2010.09-0486
[9]
Baler, J.D., Halperin, H., Edward, K., Deeker, M. and Stephens, D. (1992) Antibody Response to Bordetella pertussis Antigen after Immunization with American and Canadian Whole-Cell Vaccines. The Journal of Pediatrics, 121, 23-27. https://doi.org/10.1016/S0022-3476(05)81138-2
[10]
Federal Republic of Nigeria Official Gazzette, Abuja, Cross River State (2009) National Population Commission Census 2006 Final Results. vol. 96, B1-42.
[11]
Olusanya, O., Okpere, E. and Ezimokliai, M. (1985) Importance of Social Class in Voluntary Fertility Control in a Developing Country. West African Journal of Medicine, 4, 5-12.
[12]
Bassey, G.E., Ekanem, E.E., Okpara, H.C. and Eyong, K.I. (2020) Pertussis Antibody Level in Preschool Nigerian Children. Journal of Pediatrics Infectious Diseases, 15, 11-15. https://doi.org/10.1055/s-0039-1693484
[13]
Gergen, P.J., McQuillian, G.M., Kiely, M., Ezzati-Rice, T.M., Sutter, R.W. and Virella, G. (1995) A Population-Based Serologic Survey of Immunity to Tetanus in the United States. New England Journal of Medicine, 332, 761-766. https://doi.org/10.1056/NEJM199503233321201
[14]
Ulefet, V., Nilay, G., Naci, O., Cemile, B., Serap, K. and Demet, K. (2005) Seroprevalance of Bordetella pertussis Antibodies among Healthy Adolescent Girls in Edrine. Swiss Medical Weekly, 135, 531-536.
[15]
Hitt, S., Sangeeta, Y., Sanjay, L., Subliash, K., Suresh, J., Sameer, P., et al. (2013) Antibody Persistence of Two Pentavalent DTwP-HB-Hib Vaccine to Age of 15-18 Months and Response to the Booster Dose of Quadrilateral DTwP-Hib Vaccine. Vaccine, 31, 444-447. https://doi.org/10.1016/j.vaccine.2012.11.038
[16]
Cepeding, M.R., Alberto, E., Versteilen, A., Ranscler, M., Bagchi, P. and De Palacio, P.L. (2016) Comparison of Immunogenicity and Safety of Pentavalent Vaccine Quivaxem in a Compact Prefilled Auto-Disabled (cPAD) Injection System versus Single-Dose Vials in Healthy Infant: A Phase 3 Open-Label, Randomized, Parallel-Group, Non-Inferiority Study. International Journal of Infectious Diseases, 46, 71-78. https://doi.org/10.1016/j.ijid.2016.02.015
[17]
Uket, H.O., Ekanem, E.E., Okpara, H.C. and Ekrikpo, U.E. (2018) Comparative Tetanus Antibody Response of Nigerian Children to Diphtheria-Pertussis-Tetanus and Pentavalent Vaccines. Nigerian Postgraduate Medical Journal, 25, 137-142. https://doi.org/10.4103/npmj.npmj_41_18
[18]
Ozkal, A., Sensory, G., Acuner, C., Belet, N. and Guney, A.K. (2012) Seroprevalence of Bordetella pertussis Immunoglobulin G Antibodies among Children in Samsun, Turkey. Turkish Journal of Pediatrics, 54, 15-19.
[19]
Rendi-Wagner, P., Tobia, J., Moerman, L., Goren, S., Green, M. and Cohen, D. (2010) The Seroepidemiology of Bordetella pertussis in Isreal—Estimate of Incidence of Infection. Vaccine, 28, 3285-3290.
[20]
Duranogolo, C., Sonmez, C., Vurucu, S., Kesik, V. and Coplu, N. (2010) Evaluation of Pertussis Immunity Status in School Children Immunized with Whole Cell Vaccine. Epidemiology & Infection, 138, 299-303. https://doi.org/10.1017/S095026880999032X
